Regeneron Pharmaceuticals Incorporated operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Regeneron Pharmaceuticals Incorporated with three other
companies in this sector in the United States:
sales of $4.89 billion
of which 50%
Endo International PLC
of which 64%
was Generics), and
Eisai Company Limited
of which 49%
was Pharmaceutical Business -Japan).
Regeneron Pharmaceuticals Incorporated reported sales of $4.86 billion
December of 2016.
increase of 18.4%
versus 2015, when the company's sales were $4.10 billion.
Sales at Regeneron Pharmaceuticals Incorporated have increased during each of the previous five years
(and since 2011, sales have increased a total of 990%).